Arne Schousboe

Arne Schousboe

Auto-generated profile, based on publicly available information

Arne Schousboe

Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark

Research Focus & Metrics

Academic Career Length

43Years (1984-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 June 2006 in Journal of Neurochemistry
Verified
Journal Article
Closed access
PDF file
LBLasse Kristoffer Bak
Lasse Kristoffer Bak
ASArne Schousboe
Arne Schousboe
HWHelle S. Waagepetersen
Helle S. Waagepetersen

21 August 2014
Verified
Book Chapter
Closed access
PDF file
ASArne Schousboe
Arne Schousboe
SSSusanna Scafidi
Susanna Scafidi
LBLasse Kristoffer Bak
Lasse Kristoffer Bak
HWHelle S. Waagepetersen
Helle S. Waagepetersen
MMMary C. McKenna
Mary C. McKenna

1 January 2013 in Frontiers in Endocrinology
Verified
Journal Article
Open access
PDF file
ASArne Schousboe
Arne Schousboe
LBLasse Kristoffer Bak
Lasse Kristoffer Bak
HWHelle S. Waagepetersen
Helle S. Waagepetersen
Glutamate and GABA are the quantitatively major neurotransmitters in the brain mediating excitatory and inhibitory signaling, respectively. These amino acids are metabolically interrelated and at the same time they are tightly coupled to the intermediary metabolism including energy homeostasis. Astrocytes play a pivotal role in the maintenance of the neurotransmitter pools of glutamate and GABA since only these cells express pyruvate carboxylase, the enzyme required for de novo synthesis of the two amino acids. Such de novo synthesis is obligatory to compensate for catabolism of glutamate and GABA related to oxidative metabolism when the amino acids are used as energy substrates. This, in turn, is influenced by the extent to which the cycling of the amino acids between neurons and astrocytes may occur. This cycling is brought about by the glutamate/GABA – glutamine cycle the operation of which involves the enzymes glutamine synthetase (GS) and phosphate-activated glutaminase together with the plasma membrane transporters for glutamate, GABA, and glutamine. The distribution of these proteins between neurons and astrocytes determines the efficacy of the cycle and it is of particular importance that GS is exclusively expressed in astrocytes. It should be kept in mind that the operation of the cycle is associated with movement of ammonia nitrogen between the two cell types and different mechanisms which can mediate this have been proposed. This review is intended to delineate the above mentioned processes and to discuss quantitatively their relative importance in the homeostatic mechanisms responsible for the maintenance of optimal conditions for the respective neurotransmission processes to operate.

1 July 2006 in Trends in Pharmacological Sciences
Verified
Journal Article
Closed access
UGU Gether
U Gether
PAP Andersen
P Andersen
OLO Larsson
O Larsson
ASA Schousboe
A Schousboe

24 April 2011 in Nature Neuroscience
Verified
Journal Article
Open access
PDF file
AKAnders Skov Kristensen
Anders Skov Kristensen
MJMeagan A Jenkins
Meagan A Jenkins
TBTue G Banke
Tue G Banke
ASArne Schousboe
Arne Schousboe
YMYuichi Makino
Yuichi Makino
STStephen F Traynelis
Stephen F Traynelis
CaMKII phosphorylates the GluA1 AMPA subunit at Ser831 to increase single channel conductance. Here, the authors show that coexpression of TARPs is required for phospho-Ser831 to increase conductance of GluA1/GluA2 receptors. Ser831 phosphorylation increases the efficiency with which each subunit can activate, increasing the likelihood of simultaneous subunit activation during gating. The function, trafficking and synaptic signaling of AMPA receptors are tightly regulated by phosphorylation. Ca2+/calmodulin-dependent kinase II (CaMKII) phosphorylates the GluA1 AMPA receptor subunit at Ser831 to increase single-channel conductance. We show that CaMKII increases the conductance of native heteromeric AMPA receptors in mouse hippocampal neurons through phosphorylation of Ser831. In addition, co-expression of transmembrane AMPA receptor regulatory proteins (TARPs) with recombinant receptors is required for phospho-Ser831 to increase conductance of heteromeric GluA1-GluA2 receptors. Finally, phosphorylation of Ser831 increases the efficiency with which each subunit can activate, independent of agonist efficacy, thereby increasing the likelihood that more receptor subunits will be simultaneously activated during gating. This underlies the observation that phospho-Ser831 increases the frequency of openings to larger conductances rather than altering unitary conductance. Together, these findings suggest that CaMKII phosphorylation of GluA1-Ser831 decreases the activation energy for an intrasubunit conformational change that regulates the conductance of the receptor when the channel pore opens.

8 November 2014 in Neurochemical Research
Verified
Journal Article
Closed access
PDF file
AWAnne B. Walls
Anne B. Walls
HWHelle S. Waagepetersen
Helle S. Waagepetersen
LBLasse Kristoffer Bak
Lasse Kristoffer Bak
ASArne Schousboe
Arne Schousboe
USUrsula Sonnewald
Ursula Sonnewald